Funding for this research was provided by:
National Institute of General Medical Sciences (R01GM101689)
Received: 23 March 2018
Accepted: 14 June 2018
First Online: 22 June 2018
Compliance with ethical standards
: Drs. Jain and Cleves have a financial interest in BioPharmics LLC, a biotechnology company whose main focus is in the development of methods for computational modeling in drug discovery.